John Hale

John Hale

Company: BLIS Technologies

Job title: Chief Technology Officer

Seminars:

Micrococcus luteus BLIS Q24™ – Development of a Novel Skin Probiotic Strain & Formulation 9:00 am

Characterising a new probiotic strain for skin health applications Formulating BLIS Q24™ into an appropriate topical delivery system The emerging evidence base supporting BLIS Q24™Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.